Antibacterial Resistance Leadership Group

The #ARLGnetwork SHREC study compared patients with E. coli blood infections susceptible to the antibiotic ceftriaxone to those with ceftriaxone-resistant infections. Learn how the study highlights the impact of #AMR on patient recovery: duke.is/ARLG-SHREC

The #ARLGnetwork SNAP study revealed key global differences in carbapenem-resistant Acinetobacter baumannii infections. Understanding these bacteria helps doctors worldwide provide better care for patients. Learn more: duke.is/ARLG-SNAP #InfectionPrevention #IDTwitter

📰The next #ARLGnetwork newsletter is coming soon! Don’t forget to subscribe to receive the latest clinical trial site spotlight, recent publications, and more network news. Sign up: duke.is/ARLG-newslette… #AMR #IDTwitter

🎥ICYMI: Learn about cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection in this recording of the #ARLGnetwork Grand Rounds, “The Why & How of the ACORN Trial,” presented by @EdQian & @toddrice_ICU, @VUMCDiscoveries: duke.is/ARLG-GR-ACORN

The #ARLGnetwork DOTS study found dalbavancin may offer a simpler alternative to standard IV antibiotic treatment for serious S. aureus bloodstream infections – it can be as effective with fewer treatment changes due to side effects. Learn more: duke.is/ARLG-DOTS

The #ARLGnetwork values every participant’s contribution & is committed to sharing easy-to-read summaries that explain why studies matter, what was learned, & how results can help patients & researchers. Read study summaries: duke.is/ARLG-results #ClinicalResearch #IDTwitter

DYK? The #ARLGnetwork manages a biorepository of #GramPositive and #GramNegative bacteria for the #AMR research community, including industry partners, to use in clinical studies. Learn more: duke.is/ARLG-Bioreposi… #IDTwitter

DYK? The #ARLGnetwork has a variety of resources for industry partners to support clinical trials and new research projects, including guidance from ARLG experts, access to clinical specimens, and the MASTERMIND protocol. Learn more: arlg.org/how-to-apply/i… #AMR #IDTwitter

📢#ARLGnetwork Grand Rounds this Friday, Feb 27! “The Why & How of the ACORN Trial” presented by @EdQian & @toddrice_ICU, @VUMCDiscoveries. Check your email for the invite & join us to learn about the trial of cefepime vs piperacillin-tazobactam in adults with acute infection.

📚The #ARLGnetwork has published over 300 manuscripts with more than 200 including ARLG trainees as co-authors! Learn more about our work to combat the antibacterial resistance crisis and improve patient care: duke.is/ARLG-Publicati… #AMR #IDTwitter

📢Check your email for an invite to the #ARLGnetwork Grand Rounds on Feb 27! “The Why & How of the ACORN Trial” will be presented by @EdQian & @toddrice_ICU, @VUMCDiscoveries. Join us to learn about cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection.

📢The #ARLGnetwork provides lay summaries of study results so patients, clinicians, and researchers can learn about ARLG studies in #AMR and how the results can be used to improve patient care. Read the summaries: arlg.org/summary-of-res… #IDTwitter

🎉Congratulations to #ARLGnetwork Fellow Natalie Mackow, MD, MSCR, who received the #IDWeek2025 SHEA Trainee award for her abstract. Learn about Dr. Mackow's important work to improve outcomes for patients with severe burns: arlg.org/natalie-mackow…

ICYMI: Check out this #ARLGnetwork Grand Rounds presentation on #bacteriophages for multidrug-resistant #GramNegative ESKAPE pathogens, presented by Mikeljon Nikolich, PhD, Chief of Bacteriophage Therapeutics at Walter Reed Army Institute of Research: arlg.org/bacteriophage-…

ICYMI: #ARLGnetwork member Dr. Cesar Arias @SuperBugDoc was awarded the #IDWeek2025 Maxwell Finland Lecture! View a recording on IDWeek.org & check out the list of other sessions where ARLG members shared their expertise in #AMR: arlg.org/arlg-at-idweek…

A recent paper co-authored by #ARLGnetwork grant recipient Dr. Ahmed Babiker outlines the relationship between microorganisms & organ function & describes challenges as well as potential solutions in microbe-targeted therapeutics to advance patient care: pubmed.ncbi.nlm.nih.gov/40721656

ICYMI: The #IDWeek2025 SHEA Lectureship was presented by #ARLGnetwork Mentoring Committee Chair Dr. Anthony Harris. View the recording on IDWeek.org & check out the list of other sessions where ARLG members shared their expertise in #AMR: arlg.org/arlg-at-idweek…

📢 Study milestone alert: The #ARLGnetwork INNOVATIONS QoL second study submitted a manuscript! The study team interviewed clinicians of patients & patients with complicated UTIs to compare perceptions of patients’ quality of life. Learn more: arlg.org/arlg-studies

ICYMI: Dr. Fowler, #ARLGnetwork co-PI, presented at #IDWeek2025 on molecular diagnostics for S. aureus blood stream infection. View the recording on IDWeek.org & see a list of other sessions where ARLG members shared their expertise in #AMR: arlg.org/arlg-at-idweek…

Read the press release here: ashpfoundation.org/News-and-Event…